Morgan Stanley’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $136K | Sell |
|
|||||
|
2024
Q4 | $221K | Sell |
|
|||||
|
2024
Q3 | $264K | Buy |
|
|||||
|
2024
Q2 | $112K | Buy |
|
|||||
|
2024
Q1 | $80.1K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $21 | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $2K | Sell |
|
|||||
|
2021
Q3 | $390K | Buy |
|
|||||
|
2021
Q2 | $406K | Buy |
|
|||||
|
2021
Q1 | $255K | Buy |
|
|||||
|
2020
Q4 | $8K | Buy |
|
|||||
|
2020
Q3 | $0 | Hold |
|
|||||
|
2020
Q2 | $0 | Buy |
|
|||||
|
2020
Q1 | $0 | Hold |
|
|||||
|
2019
Q4 | $0 | Hold |
|
|||||
|
2019
Q3 | $0 | Hold |
|
|||||
|
2019
Q2 | $0 | Sell |
|
|||||
|
2019
Q1 | $2K | Buy |
|
|||||
|
2018
Q4 | $0 | Sell |
|
|||||
|
2018
Q3 | $0 | Hold |
|
|||||
|
2018
Q2 | $1K | Hold |
|
|||||
|
2018
Q1 | $1K | Sell |
|
|||||
|
2017
Q4 | $3K | Sell |
|
|||||
|
2017
Q3 | $7K | Sell |
|
|||||
|
2017
Q2 | $69K | Buy |
|
|||||
|
2017
Q1 | $102K | Sell |
|
|||||
|
2016
Q4 | $286K | Buy |
|
|||||
|
2016
Q3 | $104K | Buy |
|
|||||
|
2016
Q2 | $81K | Sell |
|
|||||
|
2016
Q1 | $212K | Sell |
|
|||||
|
2015
Q4 | $330K | Buy |
|
|||||
|
2015
Q3 | $226K | Buy |
|
|||||
|
2015
Q2 | $321K | Buy |
|
|||||
|
2015
Q1 | $456K | Buy |
|
|||||
|
2014
Q4 | $104K | Sell |
|
|||||
|
2014
Q3 | $72K | Sell |
|
|||||
|
2014
Q2 | $91K | Buy |
|
|||||
|
2014
Q1 | $10K | Sell |
|
|||||
|
2013
Q4 | $63K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $393K | Buy |
|